Home » Stocks » Axcella Health

Axcella Health, Inc. (AXLA)

Stock Price: $5.09 USD -0.05 (-0.97%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 182.42M
Revenue (ttm) n/a
Net Income (ttm) -62.47M
Shares Out 35.84M
EPS (ttm) -2.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $5.09
Previous Close $5.14
Change ($) -0.05
Change (%) -0.97%
Day's Open 5.19
Day's Range 4.96 - 5.27
Day's Volume 263,008
52-Week Range 2.25 - 9.63

More Stats

Market Cap 182.42M
Enterprise Value 131.88M
Earnings Date (est) Aug 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 35.84M
Float 10.87M
EPS (basic) -2.89
EPS (diluted) -2.94
FCF / Share -2.39
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 359,903
Short Ratio 0.16
Short % of Float 0.33%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 3.86
Revenue n/a
Operating Income -60.87M
Net Income -62.47M
Free Cash Flow -55.37M
Net Cash 50.54M
Net Cash / Share 1.41
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -51.24%
ROE -147.07%
ROIC -291.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(253.63% upside)
Current: 5.09
Target: 18.00
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-57.44-33.90-28.92
Net Income-59.04-36.07-30.94
Shares Outstanding16.624.554.21
Earnings Per Share-3.55-7.97-7.37
Operating Cash Flow-50.96-30.71-26.86
Capital Expenditures-0.12-0.59-0.92
Free Cash Flow-51.08-31.30-27.78
Cash & Equivalents92.0579.4746.82
Total Debt24.9024.5219.56
Net Cash / Debt67.1654.9527.26
Book Value60.22-150-116
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Axcella Health, Inc.
Country United States
Employees 69
CEO William R. Hinshaw

Stock Information

Ticker Symbol AXLA
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: AXLA


Axcella Health Inc., a clinical-stage biotechnology company, researches and develops endogenous metabolic modulators (EMMs) for the treatment of complex diseases and improving health in the United States. It offers AXA1665 for use in treating overt hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic steatohepatitis; AXA2678 for use in treating muscle atrophy; and AXA4010 to target multiple biological pathways to support normal structures and functions of the blood. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was founded in 2008 and is based in Cambridge, Massachusetts.